$DGX

Quest Diagnostics disclosed a data breach in its Quanum Lab Services Manager system, exposing patient records, including names, Social Security numbers, and medical information. The breach was contained, but the exact number of affected individuals is still under investigation. Quest will notify impacted patients and offer identity theft monitoring services. The company serves 1 in 3 American adults annually.

Quest Diagnostics disclosed a cyber breach affecting an unspecified number of patient records. The company is investigating the incident. Former President Barack Obama campaigned in Michigan to support Democratic Senate nominee Abdul El-Sayed. The New York Archdiocese agreed to an $800 million settlement with survivors of clergy abuse.

Quest Diagnostics reported unauthorized access to its Quanum Lab Services Manager (LSM) system, affecting some patient data. The company has remediated the incident and restored the system, but the scope of the data breach is still under investigation. Quest's core business operations were not impacted, and it plans to notify affected patients and providers. The cause and extent of the breach remain unknown.

Quest Diagnostics (DGX) released its Q3 2026 report, showing strong revenue from clinical testing but facing valuation concerns. The company has a GF Score of 76/100, with strengths in market presence and innovation, but weaknesses in financial stability and legal challenges. Opportunities include growing demand for diagnostic services and healthcare IT solutions, while threats include competition and regulatory risks. The stock is currently overvalued by about 20% according to GF Value.

Hospital security teams addressed two critical PHP flaws, patched by the PHP project on Oct. 21, with urgent guidance from CISA, NSA, and FBI. Quest Diagnostics disclosed a breach of its Quanum Lab Services Manager, unrelated to the PHP flaws. The incidents highlight risks from open-source code and vendor platforms. Kentucky's Medicaid breach and SafePay ransomware warnings add to concerns. The AHA advised hospitals to review patching and vendor security standards.

Quest Diagnostics (DGX) reported Q3 revenue of $3.10B, up 10% YoY, and adjusted EPS of $3.00, up 15%. The company raised its FY26 revenue and adjusted EPS guidance. DGX disclosed a cybersecurity incident, causing a share price drop. It plans to offer a lab test kit via Apple Health and has made strategic acquisitions and testing expansions.

Quest Diagnostics' average price target increased to $254.5 from $252.36 by 14 analysts, implying 7% upside from Oct. 21 close. Consensus rating remains 'Buy' among 20 analysts.

Quest Diagnostics reported unauthorized access to its Quanum LSM system, potentially exposing patient records. The breach is under investigation, and the company has notified authorities. Quest's Q3 revenue was $3.10 billion, beating estimates. Shares fell 3.7% premarket.

QUEST DIAGNOSTICS INC (DGX) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. On October 21, 2026, Quest Diagnostics Incorporated (the “Company”) learned of unauthorized access to its Quanum LSM system, which certain clients use to place test orders, receive and look up results. The Company promptly initiated its cybersecurity inci

Quest Diagnostics reported Q3 2026 revenue of $3.10B, up 10% YoY, and adjusted EPS of $3.00, up 15.4%. The company raised full-year 2026 revenue guidance to $12.065B-$12.105B and adjusted EPS to $11.25-$11.35. Growth was driven by strong organic performance and strategic initiatives. Quest also announced partnerships and product expansions in diagnostics and healthcare.